3sbio Inc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares 3sbio Inc with three other
companies in this sector in CHINA :
Zhejiang Huahai Pharmaceutical
(2019
sales of 5.39 billion Chinese Renmimbi [US$789.25 million]
of which 48%
was Drug Sale),
FUREN Group Pharmaceutical Co Ltd
(5.17 billion Chinese Renmimbi [US$757.27 million]
of which 83%
was Pharmaceutical Industry), and
Harbin Gloria Pharmaceuticals Co., Ltd
(5.05 billion Chinese Renmimbi [US$740.29 million]
of which 81%
was Pharmaceutical Manufacturing).
Sales Analysis.
3sbio Inc reported sales of 5.32 billion Chinese Renmimbi (US$778.99 million)
for the
year ending
December of 2019.
This
represents
an
increase of 16.0%
versus 2018, when the company's sales were 4.58 billion Chinese Renmimbi.
Sales at 3sbio Inc have increased during each of the previous five years
(and since 2014, sales have increased a total of 370%).